MOBXWNasdaqSemiconductors & Related DevicesUS GAAP · USD

Mobix Labs, Inc

Mobix Labs, Inc. designs and develops semiconductor and RF connectivity solutions, with a focus on mmWave wireless ICs and related products for defense, aerospace, industrial, commercial, and medical applications. The company has also expanded through acquisitions, adding capabilities in aerospace, military, defense, medical, and EMI-related markets.

Liikevaihto9,9milj. USD
+53,9 %v/v
Liikevoitto (EBIT)−37,7milj. USD
+18,8 %v/v
EBIT-marginaali−380,3%
+339,9 %-yks.v/v
Nettotulos−46,1milj. USD
−130,3 %v/v
Vapaa kassavirta−10,1milj. USD
+45,0 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2021–2025

−60−40−20020milj. USD2021: EBIT −0,76 milj. USD20212022: EBIT −1,3 milj. USD20222023: 1,2 milj. USD2023: EBIT −36 milj. USD20232024: 6,4 milj. USD2024: EBIT −46 milj. USD20242025: 9,9 milj. USD2025: EBIT −38 milj. USD20259,9−38
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
mmWave wireless ICs35 %

Millimeter-wave integrated circuits under development and commercialization for wireless connectivity applications.

Defense and aerospace RF solutions40 %

Semiconductor and connectivity products sold into defense, aerospace, and mission-critical systems.

EMI solutions15 %

Electromagnetic interference-related products and solutions added through acquisition.

Industrial and commercial applications10 %

Products used in industrial, commercial, and other non-defense end markets.

Tuotteet

Raportoitu · osuus liikevaihdosta
60,5%39,5%FY2025100 %
  • Products60,5 %
  • Services39,5 %

Lähde: 10-K FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.

Asiakkaat

Mobix Labs sells primarily to organizations that integrate its products into defense, aerospace, commercial, industrial, and medical systems. The company also targets OEMs and ODMs for future mmWave IC sales, but current revenue is concentrated, with Leidos Holdings accounting for about half of fiscal 2025 net revenue.

Defense and aerospace integrators

Buy RF, connectivity, and EMI-related components for mission-critical platforms and systems.

Commercial and industrial customers

Buy semiconductor and connectivity products for non-defense applications where performance and reliability matter.

OEMs and ODMs

Potential future buyers of mmWave ICs once products complete development and enter production.

Large strategic account customers

Anchor customers such as Leidos that currently represent a substantial share of revenue.

Strategia

Mobix Labs is focused on commercializing mmWave wireless technology while broadening its product base through acquisitions and adjacent defense/aerospace offerings. Near-term strategy appears centered on winning design-ins, expanding customer relationships, and reducing dependence on a small number of accounts.

Commercialize mmWave wireless productsLyhyt aikaväli

Future growth depends on converting development work into revenue-generating products.

Diversify customer concentrationKeskipitkä aikaväli

Revenue is highly dependent on a small number of customers, increasing volatility and downside risk.

Integrate acquisitions and adjacent capabilitiesKeskipitkä aikaväli

Acquisitions can add products and market access, but only if integration is successful.

Maantiede

The company is headquartered in the United States and appears to generate most of its business through U.S.-based customers and programs. Its supply chain also depends on third-party suppliers outside the United States, including manufacturing exposure in Taiwan and broader offshore sourcing risk.

Riskit

Mobix Labs faces concentrated-customer risk, product-development risk, and going-concern/capital-raising risk typical of an early-stage semiconductor company. Its business also depends on successful qualification, supply-chain continuity, and adoption of new mmWave technologies in markets that are still developing.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Capital raising and going concern1Early-stage commercialization risk3Customer concentration2Supply chain disruption4Customer qualification and adoption risk5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Capital raising and going concernVaikutus: KriittinenTodennäköisyys: Korkea

    The company expects to need additional financing and has disclosed substantial doubt about its ability to continue as a going concern.

    Kohdistuu: Liquidity and dilution risk

  2. Customer concentrationVaikutus: KriittinenTodennäköisyys: Kohtalainen

    Leidos accounted for about 50% of fiscal 2025 net revenue, so losing that account would materially reduce sales.

    Kohdistuu: Single-customer dependence

  3. Early-stage commercialization riskVaikutus: KorkeaTodennäköisyys: Korkea

    The company is still developing mmWave products, and demand timing/scale is uncertain.

    Kohdistuu: mmWave wireless products

  4. Supply chain disruptionVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Mobix Labs relies on third-party suppliers, including offshore sources, which can be affected by geopolitical and logistics issues.

    Kohdistuu: Taiwan and other overseas suppliers

  5. Customer qualification and adoption riskVaikutus: KeskitasoTodennäköisyys: Korkea

    Semiconductor customers often require lengthy qualification, delaying revenue conversion.

    Kohdistuu: Design-in cycle timing

Kirjanpito

Harkinnanvaraiset erät
Earnout liability fair value

The company remeasures earnout shares using a Monte Carlo model, so volatility and term assumptions can move earnings.

Vaikutus: Non-cash gains or losses in the income statement

Liability-classified warrants

Warrants are marked to fair value, creating periodic remeasurement effects.

Vaikutus: Can add volatility to net income

Goodwill impairment

Acquisitions create goodwill that must be tested annually or when indicators arise.

Vaikutus: Potential large non-cash impairment charges

Long-lived asset impairment

The company recognized impairment losses on long-lived assets in recent years, showing sensitivity to underperformance.

Vaikutus: Reduces asset values and earnings

Stock-based compensation

As an early-stage company, equity compensation can be a meaningful operating expense.

Vaikutus: Affects reported margins and loss levels

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 24.9.2026